188 related articles for article (PubMed ID: 24833450)
1. Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation.
Kohn JC; Rootman DB; Liu W; Goh AS; Hwang CJ; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2014; 30(5):400-4. PubMed ID: 24833450
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid gel injection for dysthyroid upper eyelid retraction in Asian patients.
Young SM; Kim JH; Kim YD; Karnsiritanont V; Lang SS; Woo KI
Orbit; 2023 Aug; 42(4):389-396. PubMed ID: 36082627
[TBL] [Abstract][Full Text] [Related]
3. Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction.
Joos ZP; Sullivan TJ
Clin Exp Ophthalmol; 2017 Aug; 45(6):651-652. PubMed ID: 28248444
[No Abstract] [Full Text] [Related]
4. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease.
Salour H; Bagheri B; Aletaha M; Babsharif B; Kleshadi M; Abrishami M; Bagheri A
Orbit; 2010 Apr; 29(2):114-8. PubMed ID: 20394553
[TBL] [Abstract][Full Text] [Related]
5. Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.
Byun JS; Lee JK
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):2001-2008. PubMed ID: 29959506
[TBL] [Abstract][Full Text] [Related]
6. Nonsurgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler.
Mancini R; Khadavi NM; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2011; 27(1):1-3. PubMed ID: 20551854
[TBL] [Abstract][Full Text] [Related]
7. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy.
Xu D; Liu Y; Xu H; Li H
Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage.
Costa PG; Saraiva FP; Pereira IC; Monteiro ML; Matayoshi S
Eye (Lond); 2009 Apr; 23(4):767-73. PubMed ID: 18535592
[TBL] [Abstract][Full Text] [Related]
9. Use of hyaluronic acid gel in the treatment of lagophthalmos in sunken superior sulcus syndrome.
Leyngold IM; Berbos ZJ; McCann JD; Pariseau B; Leyngold AR; Anderson RL
Ophthalmic Plast Reconstr Surg; 2014; 30(2):175-9. PubMed ID: 24614548
[TBL] [Abstract][Full Text] [Related]
10. The success rate of TED upper eyelid retraction reoperations.
Golan S; Rootman DB; Goldberg RA
Orbit; 2016 Dec; 35(6):335-338. PubMed ID: 27560939
[TBL] [Abstract][Full Text] [Related]
11. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.
Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823
[TBL] [Abstract][Full Text] [Related]
12. Contralateral Mueller's muscle-conjunctiva resection: a therapeutic option in thyroid eye disease patients with unilateral eyelid retraction.
Saonanon P; Potita P
Orbit; 2020 Apr; 39(2):98-101. PubMed ID: 31162982
[No Abstract] [Full Text] [Related]
13. Levator excursion as a predictor of both eyelid lag and lagophthalmos in thyroid eye disease.
Lelli GJ; Duong JK; Kazim M
Ophthalmic Plast Reconstr Surg; 2010; 26(1):7-10. PubMed ID: 20090475
[TBL] [Abstract][Full Text] [Related]
14. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy].
Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335
[No Abstract] [Full Text] [Related]
15. Change in upper eyelid position after teprotumumab treatment for thyroid eye disease.
Rosenblatt TR; Chiou CA; Yoon MK; Lee NG; Wolkow N; Freitag SK
Orbit; 2024 Jun; 43(3):337-343. PubMed ID: 38466206
[TBL] [Abstract][Full Text] [Related]
16. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.
Lee JM; Lee H; Park M; Baek S
J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303
[TBL] [Abstract][Full Text] [Related]
17. Use of hyaluronic Acid gel in the management of paralytic lagophthalmos: the hyaluronic Acid gel "gold weight".
Mancini R; Taban M; Lowinger A; Nakra T; Tsirbas A; Douglas RS; Shorr N; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2009; 25(1):23-6. PubMed ID: 19273918
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type a for dysthyroid upper eyelid retraction.
Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE
Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723
[TBL] [Abstract][Full Text] [Related]
19. Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography.
Volpe NJ; Sbarbaro JA; Gendron Livingston K; Galetta SL; Liu GT; Balcer LJ
Am J Ophthalmol; 2006 Jul; 142(1):75-81. PubMed ID: 16815253
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous ipsilateral transconjunctival repair of upper and lower eyelid retraction in thyroid-associated ophthalmopathy.
Lee NG; Habib L; Hall J; Freitag SK
Orbit; 2019 Apr; 38(2):124-129. PubMed ID: 29742012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
